SBW — Shekel Brainweigh Share News
0.000.00%
TechnologySpeculativeMicro Cap
- AU$4.43m
- AU$38.34m
- $27.19m
ASX-listed Shekel Brainweigh jumps on Q4 revenue growth
Brief: Shekel Brainweigh Posts Revenue US$7.65M In Q4-2024
Brief: Shekel Brainweigh Says ASX Confirmed It Had Agreed To Remove Shekel From Official List
Brief: Shekel Brainweigh Requests Trading Halt Pending Delisting Announcement
Brief: Shekel Brainweigh Says H1 2024 Expected To Show Significant Improvement
Brief: Shekel Brainweigh Appoints Sagi Cohen As New Chairman Of Board & CEO
Brief: Shekel Brainweigh Reaches Deal With Lenders To Provide Additional Funds
Brief: Shekel Brainweigh Posts FY Unaudited Revenue $27.2M
Brief: Shekel Brainweigh Well Equipped To Deliver Products In Timely Manner To Its Customers
Brief: Shekel Brainweigh Says Revenue For H1 2023 Grew To $13.4 Mln (Unaudited)
Brief: Shekel Brainweigh Says CY2023 YTD Group Revenue $10.73 Mln
Brief: Shekel Brainweigh's Unit Launches Loan And Option Agreement
Brief: Shekel Brainweigh Reports FY22 Revenue Of $26.3 Million
Brief: Shekel Brainweigh Says It Is On Track For Revenue Of $7.5 Mln In Q4
Brief: Shekel Brainweigh Says Shekel To Sell Healthweigh Line Of Medical Scales Products
Brief: Shekel Brainweigh Says Seeks Trading Halt
ASX-listed Shekel Brainweigh gains on higher H1 revenue
Brief: Shekel Brainweigh Says H1 FY22 Revenue Grew By 23% To US$13.1 Mln
Brief: Shekel Brainweigh's Unit Enters Loan & Option Deal With MTCP II LLC & Others